VWA
Visionary Wealth Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.18M | Buy |
213,000
+8,218
| +4% | +$316K | 0.42% | 66 |
|
|
2025
Q1 | $7.93M | Buy |
204,782
+11,404
| +6% | +$442K | 0.48% | 60 |
|
|
2024
Q4 | $6.54M | Buy |
193,378
+10,178
| +6% | +$344K | 0.38% | 76 |
|
|
2024
Q3 | $7.49M | Buy |
183,200
+22,930
| +14% | +$937K | 0.46% | 68 |
|
|
2024
Q2 | $6.17M | Buy |
160,270
+70,772
| +79% | +$2.72M | 0.4% | 69 |
|
|
2024
Q1 | $3.84M | Sell |
89,498
-4,136
| -4% | -$177K | 0.26% | 104 |
|
|
2023
Q4 | $3.47M | Buy |
93,634
+131
| +0.1% | +$4.86K | 0.26% | 112 |
|
|
2023
Q3 | $3.39M | Buy |
93,503
+2,798
| +3% | +$101K | 0.27% | 101 |
|
|
2023
Q2 | $3.23M | Buy |
90,705
+4,365
| +5% | +$156K | 0.26% | 103 |
|
|
2023
Q1 | $3.07M | Buy |
86,340
+78,514
| +1,003% | +$2.79M | 0.26% | 99 |
|
|
2022
Q4 | $275K | Buy |
+7,826
| New | +$275K | 0.03% | 339 |
|
|
2022
Q2 | – | Sell |
-5,706
| Closed | -$249K | – | 452 |
|
|
2022
Q1 | $249K | Sell |
5,706
-219
| -4% | -$9.56K | 0.02% | 367 |
|
|
2021
Q4 | $261K | Buy |
+5,925
| New | +$261K | 0.02% | 320 |
|
|
2020
Q4 | – | Sell |
-7,078
| Closed | -$266K | – | 295 |
|
|
2020
Q3 | $266K | Sell |
7,078
-2
| -0% | -$75 | 0.04% | 204 |
|
|
2020
Q2 | $289K | Sell |
7,080
-446
| -6% | -$18.2K | 0.04% | 179 |
|
|
2020
Q1 | $285K | Sell |
7,526
-19
| -0.3% | -$720 | 0.05% | 156 |
|
|
2019
Q4 | $354K | Buy |
+7,545
| New | +$354K | 0.06% | 151 |
|